Canaccord Genuity maintains a 'Buy' on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) price target of $52.00.

Analyst, Salveen Richter, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE